共查询到20条相似文献，搜索用时 234 毫秒
1.
2.
乳糖存在于乳汁中.因肠道乳糖酶的缺乏而致乳糖不消化并出现症状称为乳糖不耐受(lactoseintolerance),这一问题牵涉到全世界半数以上的人口.我国人口的绝大多数体内缺乏乳糖酶.随着乳品应用的扩大,此情况就越显严重.应该研究相应的对策. 相似文献
3.
4.
5.
6.
在实际工作中,一般我们会采用两种方法来对弱电设备的电气连接能耐受电压能力进行试验,第一种也就是差模试验,即将相邻两根不同的绝缘导线,其中,一根芯线进行接地处理,另一根则需要连接到高压位置,然后对这两根芯线进行分析,了解其承受差模高压的力。第二就是工模试验,也就是将一根芯线进行接地处理,并在绝缘层外部缠绕一定的导线,最后再接入到高压端,以承受高压。本文就这两种试验方法来对弱电设备电气连接等耐受过电压能力进行深入分析。 相似文献
7.
8.
雨水管网是城市防洪排涝体系中重要的组成部分,科学合理的雨水管网设计,对建设海绵城市、缓解消除城市内涝问题具有重要意义。建立以降低造价同时提高雨水系统排水能力的多目标优化设计模型,以管径值为决策变量,利用Borg多目标优化算法求解,基于c语言运行平台,将SWMM源代码嵌入寻优过程,从而实现程序自动调用源码计算引擎,得到大量满足约束条件的方案解集;在此基础上,提出雨水管网耐受度概念,利用正态分布模拟降雨空间分布的差异性,从而辅助决策者甄选方案。将设计思路应用于工程实例,结果表明,以优化再加耐受度评估方式,对于雨水管网设计具有较好的实际应用价值。 相似文献
9.
10.
由于温室效应带来气候变化及各种环境问题，耐受极高CO2浓度藻类的研究与应用已得到越来越广泛的关注。本文综述了极高CO2浓度对耐受性藻类在生长、生理生化和分子水平上的影响，以及藻类适应极高CO2浓度的机理，并结合藻类生物技术分析了耐受性藻类在生物固碳领域的应用前景和途径，在此基础上，提出了一种利用藻类固定CO2以缓解日趋严重的温室效应的新思路。 相似文献
11.
[目的]研究促红细胞生成素对全脑缺血再灌注大鼠缺氧诱导因子1α和凋亡相关蛋白存活素的调节,探讨其抗凋亡的可能机制。[方法]将成年雄性SD大鼠75只按随机数字表法分为全脑缺血组（n=35）和全脑缺血EPO干预组（n=35）,然后按再灌注时间不同又分为6h、12h、24h、48h、72h、5d和7d七个亚组。采用改良的Pu刘lsineli 4-VO法制作全脑缺血大鼠模型。应用TUNEL染色检测再灌注后不同时间点海马CA1区的神经元凋亡水平,免疫组织化学方法检测再灌注后不同时间点海马CA1区缺氧诱导因子1α和存活素表达水平的变化。[结果]全脑缺血EPO干预组24h至7d亚组TUNEL阳性神经元计数分别为1.50±0.73、3.14±0.88、5.78±1.03、7.78±1.79、10.34±1.82.与全脑缺血组相应时间点亚组相比明显减少,差异均有统计学意义（P〈0.05）。全脑缺血EPO干预组48h至5d亚组HIF-1α表达阳性细胞计数分别为11.26±0.02、20.28±2.03、3.33±0.04,与全脑缺血组相应时间点亚组相比明显减少,差异均有统计学意义（P〈0.05）.全脑缺血EPO干预组24h至5d亚组survivin蛋白表达阳性细胞计数分别为12.21±1.04、16.34±4.02、24.33±3.03、30.52±5.04,与全脑缺血组相应时间点亚组相比明显增高,差异均有统计学意义（P〈0.05）。[结论]在全脑缺血急性期,EPO抑制HIF-1α的表达而使存活素表达升高,具有一定的神经保护作用. 相似文献
12.
Shaymaa M. M. Yahya Shadia A. Fathy Zakaria A. El-Khayat Safinaz E. El-Toukhy Ahmed R. Hamed Marwa G. A. Hegazy Heba K. Nabih 《Indian journal of clinical biochemistry : IJCB》2018,33(1):21-30
Hepatocellular carcinoma (HCC) is a hypervascular primary liver cancer characterized by rapid progression, besides, resistance to traditional chemotherapeutic agents. It has been shown that microRNAs play critical roles in regulation of tumor cell sensitivity to drugs through modulating the expression of genes involved in drug transport. The present study investigated whether restoration of miR-122 in HCC cells could alter the cell cycle distribution and the expression of multidrug resistance (MDR)-related genes (ABCB1, ABCC1, ABCG2 and ABCF2). After overexpression of miR-122 in HepG2 cells treated or untreated with doxorubicin doses, total RNAs and protein extracts were isolated for application of QRT-PCR and western blotting techniques. Moreover, cell cycle distribution was monitored by flow cytometry. Our results revealed that, the over expression of miR-122 in HepG2 cells treated or untreated with doxorubicin could modulate the sensitivity of cells to chemotherapeutic drug through downregulation of MDR-related genes, ABCB1 and ABCF2. Interpretation of cell cycle distribution revealed that, the anti-proliferative effect of miR-122 is associated with the accumulation of cells in G0/G1 phase. Moreover, treatment with miR-122 and doxorubicin resulted in high percentage of HCC cells in G0/G1 phase. Taken together, our findings revealed that, overexpression of miR-122 inhibited HCC cell growth by inducing cell cycle arrest and this arrest is associated with down-regulation of MDR-related genes. 相似文献
13.
肿瘤多药耐药 (multidrugresistance ,MDR)是临床化疗成功最为严重的障碍 .首先阐明了新拓扑异构酶II抑制剂沙尔威辛对MDR肿瘤细胞直接的细胞毒性作用及下调mdr 1基因和P 糖蛋白的作用 .沙尔威辛能有效杀伤MDR细胞株 ,如K5 62 A0 2 ,KB VCR和MCF 7 ADR细胞 ,其杀伤能力与对相应亲本细胞相当 ,而明显强于几种临床常用的抗癌药物 .沙尔威辛下调mdr 1基因和P 糖蛋白的表达 ,但并不影响MRP和LRP基因 .其次 ,揭示了转录因子c jun的激活 ,在沙尔威辛下调K5 62 A0 2细胞内mdr 1基因表达及诱导凋亡过程中起着关键作用 .沙尔威辛增加K5 62 A0 2细胞的c jun表达明显早于其减少mdr 1基因的表达 ;c jun反义寡核苷酸消除沙尔威辛升高c jun蛋白、下调mdr 1基因表达的作用 .沙尔威辛还促进JNK和c jun磷酸化并增强转录因子AP1的DNA结合活性 .此外 ,c jun反义寡核苷酸还抑制沙尔威辛的凋亡诱导和细胞毒性作用 .最后 ,进一步研究发现沙尔威辛本身不引起MDR表型 .成功建立了对沙尔威辛具有 8 91倍耐药的A5 4 9 SAL细胞株 .该细胞株对抗代谢药产生 6.70倍的耐药 ,但对多种其他天然来源的抗肿瘤药物、烷化剂以及铂类化合物则缺乏交叉耐药性 . 相似文献
14.
抗生素除了大量用于人类疾病的治疗外,还作为饲料添加剂被广泛应用于动物养殖业。微生物的抗生素耐药性就是指微生物能够在抗生素存在的情况下生长和繁殖。抗生素耐药性是环境微生物固有的,即所谓的内在抗性,但是人类大量使用抗生素带来的抗生素抗性基因的扩散和传播普遍存在,且已开始威胁到全球人群的健康。微生物对抗生素的抗性主要有3个机制:(1)抗生素的外排;(2)抗生素的降解或修饰;(3)抗生素作用位点的保护。大量研究表明,抗生素的使用和抗生素抗性的蔓延呈现良好的相关性,而且环境微生物的抗性可以通过基因横向转移向人类致病菌扩散,最终可能导致超级细菌的爆发,直接影响人类健康。为了应对全球性的抗生素抗性问题,必须加强:(1)全球抗生素使用和环境排放的监管政策和管理体系;(2)建立快速和透明的抗生素耐药性监测体系,使其涵盖医院、养殖业、污水处理厂等;(3)建立抗生素药物创新基金,通过政府和企业的联合,加快新型药物的研制;同时加强知识产权保护,使新药创制走上可持续之路;(4)加强抗生素耐药性相关的基础与应用研究,包括耐药性发生和传播的生态学机制,消除和缓解耐药性发生和传播的环境技术及其系统解决方案等,包括改进污水处理厂的处理工艺,削减出水中抗性基因和抗性菌的比例;(5)加强抗生素耐药性的科普宣传,提高全社会对耐药性的认知能力,从而在源头上有效控制抗生素在农业和医疗方面的滥用及其环境污染。 相似文献
15.
BackgroundSuper-paramagnetic iron oxide nanoparticles (SPION) contain a chemotherapeutic drug and are regarded as a promising technique for improving targeted delivery into cancer cells.ResultsIn this study, the fabrication of 5-fluorouracil (5-FU) was investigated with loaded Dextran (DEX-SPION) using the co-precipitation technique and conjugated by folate (FA). These nanoparticles (NPs) were employed as carriers and anticancer compounds against liver cancer cells in vitro. Structural, magnetic, morphological characterization, size, and drug loading activities of the obtained FA-DEX-5-FU-SPION NPs were checked using FTIR, VSM, FESEM, TEM, DLS, and zeta potential techniques. The cellular toxicity effect of FA-DEX-5-FU-SPION NPs was evaluated using the MTT test on liver cancer (SNU-423) and healthy cells (LO2). Furthermore, the apoptosis measurement and the expression levels of NF-1, Her-2/neu, c-Raf-1, and Wnt-1 genes were evaluated post-treatment using flow cytometry and RT-PCR, respectively. The obtained NPs were spherical with a suitable dispersity without noticeable aggregation. The size of the NPs, polydispersity, and zeta were 74 ± 13 nm, 0.080 and −45 mV, respectively. The results of the encapsulation efficiency of the nano-compound showed highly colloidal stability and proper drug maintenance. The results indicated that FA-DEX-5-FU-SPION demonstrated a sustained release profile of 5-FU in both phosphate and citrate buffer solutions separately, with higher cytotoxicity against SNU-423 cells than against other cells types. These findings suggest that FA-DEX-SPION NPs exert synergistic effects for targeting intracellular delivery of 5-FU, apoptosis induction, and gene expression stimulation.ConclusionsThe findings proved that FA-DEX-5-FU-SPION presented remarkable antitumor properties; no adverse subsequences were revealed against normal cells.How to cite: Mahdia SA, Kadhimb AA, Albukhaty S, et al. Gene expression and apoptosis response in hepatocellular carcinoma cells induced by biocompatible polymer/magnetic nanoparticles containing 5-fluorouracil. Electron J Biotechnol 2021;52. https://doi.org/10.1016/j.ejbt.2021.04.001 相似文献
16.
Surapon Tangvarasittichai Suthap Pongthaisong Suwadee Meemark Orathai Tangvarasittichai 《Indian journal of clinical biochemistry : IJCB》2015,30(3):275-280
Abdominal obesity (AO) has a strong correlation with cardiovascular disease and has been linked to Alzheimer’s disease and type 2 diabetes. We investigated the association between AO and elevated serum butyrylcholinesterase (BChE) activity, insulin resistance and the serum lipid profile, including triglyceride (TG), HDL-cholesterol (HDL-C) and LDL-cholesterol (LDL-C) levels in AO and non-AO women subjects. A total of 500 AO subjects (age 49.1 ± 10.5 years), and 142 non-AO women subjects (age 49.9 ± 11.9 years) were enrolled for the general biochemistry tests, serum BChE, fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR). Body mass index, waist circumference, Blood pressure (BP), plasma glucose (Glu), triglyceride (TG), BChE, insulin, HOMA-IR were significantly higher and HDL-C levels were significantly lower in AO subjects (p < 0.05). Waist circumference was significantly correlated with BP, Glu, TG, BChE, insulin and HOMA-IR in AO subjects. Multiple logistic regression demonstrated that AO was associated with elevated BChE, HOMA-IR, hypertension and reduced HDL-C after adjusting for these variables. AO is associated with elevated BChE, insulin resistance, HT and reduced HDL-C. These may predict the development of type 2 diabetes mellitus and may be associated with cognitive disorder in the future, both are mediated through insulin resistance. 相似文献
17.
Prathama Guha Kaushik Bhowmick Piyanku Mazumder Malay Ghosal Indranil Chakraborty Prabir Burman 《Indian journal of clinical biochemistry : IJCB》2014,29(1):51-56
The levels of fasting glucose, fasting insulin, insulin resistance (IR) and the prevalence of metabolic syndrome (MS) in a sample population of bipolar disorder (BPD) patients who were newly diagnosed and psychotropically naïve were assessed and compared with an age, sex and racially matched control population. 55 BPD-I patients (15–65 years) who were non-diabetic, nonpregnant, and drug naïve for a period of at least 6 months were included in the study. Diagnosis was made using the structured clinical interview for DSM-IV axis I disorders (SCID IV). IR was assessed using homeostasis model of insulin resistance (HOMA-IR); MS was defined according to National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III). Data were compared with 25 healthy controls. BPD patients had significantly higher mean levels of fasting plasma insulin (13.2 ± 9.2 vs. 4.68 ± 3.1 μIU/ml, p < 0.05), postprandial plasma insulin (27.2 ± 14.5 vs. 18.1 ± 9.3 μIU/ml, p < 0.05) and a higher value of HOMA-IR (3.16 ± 2.2 vs. 1.19 ± 0.8, p < 0.05) when compared to the controls. A significantly higher proportion of patients of BPD compared to controls were manifesting levels of fasting plasma glucose, serum triglyceride and blood pressure higher than the cut off while waist circumference and serum HDL cholesterol failed to show any significant difference in the proportion. There was a significantly higher proportion of prevalence of IR between BPD cases and controls (26/55 vs. 2/25, z value 9.97, p < 0.05) while there was no significant difference in proportion of prevalence of MS between these two groups. Within BPD patients, logistic regression analysis showed that age, sex or current mood status (depressed/manic) were not significantly predictive of presence or absence of MS or increased IR. 相似文献
18.
P. Bubber A. Sharma A. Chauhan D. D. Bansal 《Indian journal of clinical biochemistry : IJCB》2013,28(2):193-196
Growth retardation is one of the significant changes in chronic kidney disease (CKD) and is associated with increased morbidity and mortality. Disturbances in growth hormone (GH) are held responsible for several complications in CKD. GH is a protein based peptide hormone which directly or indirectly regulates renal functions to ensure homeostasis. We investigated the effects of growth hormone on plasminogen activators (PA) in rat kidney, PA and plasminogen activator inhibitor (PAI), glucose and fibrinogen in plasma and serum lipid profile. Rats were injected daily with 250 mU GH kg-1 body weight subcutaneously for one week. Growth hormone treatment increased PA activity significantly in rat kidneys as compared to controls. No changes were seen in PA, PAI and fibrinogen levels in the plasma of two groups of rats. There was significant decrease in plasma glucose, total cholesterol and LDL-cholesterol levels in serum of treated group resulting in the decrease of HDL/LDL and total cholesterol/cholesterol ratios. However, triglycerides and VLDL showed significant higher activity in the serum of treated group as compared to controls. Our data suggests that GH administration might improve renal function by increasing PA activity in kidney as well as by reducing the cholesterol content in blood. GH may be effective in improving growth failure as it helps to maintain the normal homeostatic balance. 相似文献
19.
Anindya Dasgupta Aparna Khan Ushasi Banerjee Mrinalkanti Ghosh Mrinal Pal Kanika M. Chowdhury Sayantan Dasgupta 《Indian journal of clinical biochemistry : IJCB》2013,28(2):169-176
The purpose of this study was to assess the predictive values of central obesity and hyperandrogenemia in development of insulin resistance and dyslipidemia in the polycystic ovarian syndrome (PCOS) patients in our region. Differences of fasting blood glucose level, insulin resistance index HOMA-IR, lipid parameters, waist hip ratio (WHR), body mass index, LH/FSH ratio and testosterone levels between 45 PCOS cases and 35 age matched controls were obtained. Strength of association between different parameters in the case group was assayed by Pearson’s correlation analysis. Dependence of insulin resistance and WHR on different predictors was assessed by multiple linear regression assay. Total cholesterol, LDL cholesterol, LH, FSH, LH/FSH ratio, WHR and insulin resistance were significantly higher in the case group (p < 0.05). Serum testosterone showed strong correlation with insulin resistance and LH/FSH ratio (r = 0.432 and 0.747, p = 0.01 and 0.001 respectively) in the PCOS patients while WHR and serum testosterone level stood out to be most significant predictors for the insulin resistance (β = 0.361 and 0.498; p = 0.048 and 0.049 respectively). Hyperandrogenemia and central obesity were the major factors predicting development of insulin resistance and its related metabolic and cardiovascular complications in our PCOS patients. We suggest early monitoring for androgen level and WHR in these patients for predicting an ensuing insulin resistance and modulating the treatment procedure accordingly to minimise future cardiovascular risks. 相似文献